Home › Funds › Alphabet Inc. › BEAM
Alphabet Inc. position in BEAM
BEAM THERAPEUTICS INC · Health Care
Alphabet Inc. reported holding 321,604 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.9M, representing 0.01% of its reported portfolio and ranking #23 among its reported holdings. Alphabet Inc. has disclosed BEAM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Alphabet Inc.'s BEAM position evolved
Alphabet Inc. first disclosed a stake in BEAM in Q3 2023 at 321,604 shares (US$7.7M). The position peaked in Q2 2026 at 321,604 shares, worth US$11.0M. Across 13 filings, Alphabet Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 321,604 shares valued at US$7.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 321.60K | $7.73M | New |
| Q4 2023 | 321.60K | $8.75M | Hold |
| Q1 2024 | 321.60K | $10.63M | Hold |
| Q2 2024 | 321.60K | $7.54M | Hold |
| Q3 2024 | 321.60K | $7.88M | Hold |
| Q4 2024 | 321.60K | $7.98M | Hold |
| Q1 2025 | 321.60K | $6.28M | Hold |
| Q2 2025 | 321.60K | $5.47M | Hold |
| Q3 2025 | 321.60K | $7.81M | Hold |
| Q4 2025 | 321.60K | $8.91M | Hold |
| Q1 2026 | 321.60K | $7.66M | Hold |
| Q2 2026 | 321.60K | $11.04M | Hold |
| Q3 2026 | 321.60K | $7.86M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BEAM and 13F data
BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 31 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$288.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BEAM
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.24M sh · $351.31M · Q2 2026
- ARK Invest 11.81M sh · $288.64M · Q3 2026
- ARCH Venture Management, LLC 4.54M sh · $155.77M · Q2 2026
- Kynam Capital Management, LP 2.84M sh · $97.50M · Q2 2026
- Amova Asset Management Americas, Inc. 3.35M sh · $81.76M · Q3 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Redmile Group, LLC 1.16M sh · $39.96M · Q2 2026
- Deep Track Capital, LP 1.00M sh · $34.32M · Q2 2026
More on Alphabet Inc.
FAQ
How long has Alphabet Inc. held BEAM?
Alphabet Inc. has disclosed BEAM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Alphabet Inc.'s current position in BEAM?
As of Q3 2026, Alphabet Inc. holds 321.60K shares of BEAM (BEAM THERAPEUTICS INC), valued at $7.86M, representing 0.01% of its reported portfolio and ranking #23.
Has Alphabet Inc. been buying or selling BEAM?
In the latest 13F filing (Q3 2026), Alphabet Inc. held unchanged its position in BEAM. The position peaked in Q2 2026 at 321.60K shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.